CD33/CLL1 dual CAR-NK cell
/ Qihan Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
February 12, 2026
Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia
(clinicaltrials.gov)
- P1 | N=2 | Completed | Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Not yet recruiting ➔ Completed | N=102 ➔ 2
Enrollment change • First-in-human • Trial completion • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Oncology • CD33
August 14, 2023
Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia
(clinicaltrials.gov)
- P1 | N=102 | Not yet recruiting | Sponsor: Institute of Hematology & Blood Diseases Hospital
New P1 trial • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Oncology • CD33
1 to 2
Of
2
Go to page
1